← Leaderboards
Gregory S Hageman
University Of Iowa
$17,947,462
Attributed
$17,947,462
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2005–10$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$17,947,462 · 2
By mechanism
R24$14,773,700 · 1
R01$3,173,762 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Richard J Smith$33,390,035
- Patrick Breheny$1,404,806
- Carla M Nester$1,404,806
- Michael John Schnieders$2,340,118
- Robert Foster Mullins$9,156,220
Others in their field
Top investigators on “Mass Spectrometry”
- Michael P Rout · Rockefeller University$40,544,912
- Frank Patrick McCormick · University Of California San Francisco$35,803,407
- Catherine E. Costello · Boston University Medical Campus$34,236,146
- Ronald Wayne Davis · Stanford University$33,280,272
- John Robert Yates · Scripps Research Institute, The$30,845,643
- Donald F Hunt · University Of Virginia Charlottesville$28,182,491
Research focus
Mass SpectrometryEnzyme Linked Immunosorbent AssayPathologic ProcessMembrane StructureRetinal Pigment EpitheliumSds Polyacrylamide Gel ElectrophoresisNorthern BlottingsIn Situ HybridizationMatrix Assisted Laser Desorption IonizationMolecular PathologyBasal LaminaPolymerase Chain ReactionChoroid UveaWestern BlottingsAgingMacular DegenerationHuman TissueImmunocytochemistryMacular DrusenOrgan CultureCellular PathologyBiogenesisBasic ScienceAnimal Model
Grant awards (14)
Development of Complement Modulating Therapeutics for AMD$2,986,452
R24 · FY2010 · EY · contact PI
Development of Complement Modulating Therapeutics for AMD$2,979,061
R24 · FY2009 · EY · contact PI
Development of Complement Modulating Therapeutics for AMD$2,873,998
R24 · FY2008 · EY · contact PI
Development of Complement Modulating Therapeutics for AMD$2,927,483
R24 · FY2007 · EY · contact PI
Development of Complement Modulating Therapeutics for AMD$3,006,706
R24 · FY2006 · EY · contact PI
AGE-RELATED MACULOPATHY: CELLULAR AND MOLECULAR ANALYSES$165,462
R01 · FY2005 · EY
AGE-RELATED MACULOPATHY: CELLULAR AND MOLECULAR ANALYSES$489,763
R01 · FY2004 · EY
AGE-RELATED MACULOPATHY: CELLULAR AND MOLECULAR ANALYSES$145,736
R01 · FY2004 · EY
AGE-RELATED MACULOPATHY: CELLULAR AND MOLECULAR ANALYSES$478,876
R01 · FY2003 · EY
AGE-RELATED MACULOPATHY: CELLULAR AND MOLECULAR ANALYSES$398,536
R01 · FY2003 · EY
AGE-RELATED MACULOPATHY: CELLULAR AND MOLECULAR ANALYSES$85,000
R01 · FY2003 · EY
AGE-RELATED MACULOPATHY: CELLULAR AND MOLECULAR ANALYSES$468,304
R01 · FY2002 · EY
AGE-RELATED MACULOPATHY: CELLULAR AND MOLECULAR ANALYSES$458,040
R01 · FY2001 · EY
AGE-RELATED MACULOPATHY: CELLULAR AND MOLECULAR ANALYSES$484,045
R01 · FY2000 · EY